# A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants

> **NCT02152332** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-54861911-Therapeutic Dose
- **DRUG:** JNJ-54861911 - Supratherapeutic Dose
- **DRUG:** JNJ-54861911-Matched Placebo
- **DRUG:** Moxifloxacin
- **DRUG:** Moxifloxacin Matched Placebo

## Key facts

- **NCT ID:** NCT02152332
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02152332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02152332, "A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02152332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*